Severe Hyperbilirubinemia as a Side Effect of Three-Week Treatment with Glecaprevir/Pibrentasvir Resulting in Sustained Virologic Response

Authors :: Taseen Syed
Bryce Yohannan
Diane Hughes
Javid Fazili
Maham Hayat
Muhammad Hashim Hayat
Source :: Gastroenterology, Hepatology & Digestive Disorders. 3
Publication Year :: 2020
Publisher :: SciVision Publishers LLC, 2020.

Subjects :: medicine.medical_specialty
Side effect
business.industry
Virologic response
Internal medicine
medicine
Glecaprevir / pibrentasvir
business
Gastroenterology

Full Text Access

Tools